ACA-话题@MedSci

#ACA#

226篇内容 | 3714人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1652012, encodeId=31e11652012a9, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究, objectType=article, longId=726512, objectId=5008e26512f9, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5008e26512f9, replyNumber=0, likeNumber=119, createdTime=2023-02-03, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5008e26512f9, moduleTitle=联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5008e26512f9)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652003, encodeId=2a471652003fe, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=Endocrinol Metab：患者PRKACA L206R突变体产生皮质醇腺瘤的临床和分子特征, objectType=article, longId=294091, objectId=5fce294091de, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5fce294091de, replyNumber=0, likeNumber=80, createdTime=2022-04-14, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5fce294091de, moduleTitle=Endocrinol Metab：患者PRKACA L206R突变体产生皮质醇腺瘤的临床和分子特征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5fce294091de)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652017, encodeId=35a3165201ed6, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=CACA中国肿瘤整合诊治指南精读巡讲, objectType=article, longId=733939, objectId=8f39e3393908, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8f39e3393908, replyNumber=0, likeNumber=74, createdTime=2022-12-10, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8f39e3393908, moduleTitle=CACA中国肿瘤整合诊治指南精读巡讲, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8f39e3393908)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652005, encodeId=4d811652005d4, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：Ustekinumab治疗儿童斑块型银屑病的真实经验, objectType=article, longId=300165, objectId=0224300165af, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0224300165af, replyNumber=0, likeNumber=108, createdTime=2022-03-30, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0224300165af, moduleTitle=J Am Acad Dermatol：Ustekinumab治疗儿童斑块型银屑病的真实经验, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0224300165af)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652006, encodeId=fc4116520068a, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=尘螨变应原舌下片ACARIZAX® 豁免中国注册临床试验，2022年将提交上市许可申请, objectType=article, longId=300863, objectId=f5253008638f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f5253008638f, replyNumber=0, likeNumber=92, createdTime=2023-02-07, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f5253008638f, moduleTitle=尘螨变应原舌下片ACARIZAX® 豁免中国注册临床试验，2022年将提交上市许可申请, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f5253008638f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651998, encodeId=1cc61651998fe, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究, objectType=article, longId=293131, objectId=686729313109, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=686729313109, replyNumber=0, likeNumber=105, createdTime=2022-09-25, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=686729313109, moduleTitle=J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=686729313109)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652002, encodeId=eaca1652002fe, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Orthop Surg：过氧化氢溶液可有效减少术区痤疮杆菌的负担, objectType=article, longId=294157, objectId=316c29415e2a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=316c29415e2a, replyNumber=0, likeNumber=66, createdTime=2022-10-24, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=316c29415e2a, moduleTitle=J Am Acad Orthop Surg：过氧化氢溶液可有效减少术区痤疮杆菌的负担, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=316c29415e2a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652001, encodeId=98f81652001ef, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药, objectType=article, longId=293854, objectId=d952293854cb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d952293854cb, replyNumber=0, likeNumber=66, createdTime=2022-11-14, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d952293854cb, moduleTitle=EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d952293854cb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652011, encodeId=53b8165201128, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：古塞奇尤单抗治疗银屑病5年的安全性证据：VOYAGE 1和2研究的汇总数据, objectType=article, longId=726080, objectId=abb0e26080eb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=abb0e26080eb, replyNumber=0, likeNumber=81, createdTime=2022-05-07, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=abb0e26080eb, moduleTitle=J Am Acad Dermatol：古塞奇尤单抗治疗银屑病5年的安全性证据：VOYAGE 1和2研究的汇总数据, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=abb0e26080eb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651987, encodeId=3ec3165198e0e, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle= ACAS应该选择BMT还是CEA/CAS？, objectType=article, longId=215512, objectId=cc3e2155120c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cc3e2155120c, replyNumber=0, likeNumber=72, createdTime=2022-01-28, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cc3e2155120c, moduleTitle= ACAS应该选择BMT还是CEA/CAS？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cc3e2155120c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651991, encodeId=2684165199133, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Dermatol：外用特比萘芬10%溶液（MOB-015）可有效且安全的治疗轻中度手足癣, objectType=article, longId=218489, objectId=4ee72184893d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4ee72184893d, replyNumber=0, likeNumber=0, createdTime=2021-11-11, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4ee72184893d, moduleTitle=J Am Acad Dermatol：外用特比萘芬10%溶液（MOB-015）可有效且安全的治疗轻中度手足癣, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4ee72184893d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1652009, encodeId=0f591652009a6, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=肥厚型心肌病患者新选择！联拓生物合作伙伴百时美施贵宝公司的Camzyos (mavacamten) 获美国FDA批准, objectType=article, longId=725731, objectId=7110e25731dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7110e25731dc, replyNumber=0, likeNumber=96, createdTime=2022-06-23, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7110e25731dc, moduleTitle=肥厚型心肌病患者新选择！联拓生物合作伙伴百时美施贵宝公司的Camzyos (mavacamten) 获美国FDA批准, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7110e25731dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651997, encodeId=9079165199e00, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , objectType=article, longId=221637, objectId=357d22163ea7, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=357d22163ea7, replyNumber=0, likeNumber=82, createdTime=2022-01-10, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=357d22163ea7, moduleTitle=Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌 , moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=357d22163ea7)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651994, encodeId=c42e1651994a9, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：口服胶质蛋白保护的超氧化物歧化酶是治疗非节段型白癜风的有效补充疗法, objectType=article, longId=219588, objectId=4820219588c1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4820219588c1, replyNumber=0, likeNumber=84, createdTime=2022-08-14, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4820219588c1, moduleTitle=J Eur Acad Dermatol Venereol：口服胶质蛋白保护的超氧化物歧化酶是治疗非节段型白癜风的有效补充疗法, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4820219588c1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651993, encodeId=90741651993c8, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性, objectType=article, longId=218777, objectId=cb5a218e773e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cb5a218e773e, replyNumber=0, likeNumber=82, createdTime=2022-09-11, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cb5a218e773e, moduleTitle=J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cb5a218e773e)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651996, encodeId=7689165199658, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=NEJM： HIF-2α抑制剂Belzutifan有望用于治疗Pacak-Zhuang综合征, objectType=article, longId=221215, objectId=f8152212150a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f8152212150a, replyNumber=0, likeNumber=0, createdTime=2022-10-11, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f8152212150a, moduleTitle=NEJM： HIF-2α抑制剂Belzutifan有望用于治疗Pacak-Zhuang综合征, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f8152212150a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651988, encodeId=b075165198869, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle= J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好, objectType=article, longId=215618, objectId=f1682156183c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f1682156183c, replyNumber=0, likeNumber=61, createdTime=2022-03-17, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f1682156183c, moduleTitle= J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f1682156183c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651983, encodeId=d82b16519835d, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？, objectType=article, longId=214101, objectId=15522141014d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=15522141014d, replyNumber=0, likeNumber=82, createdTime=2022-05-27, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=15522141014d, moduleTitle=Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=15522141014d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651978, encodeId=9e1c16519e8df, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加, objectType=article, longId=207841, objectId=cea920e84114, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cea920e84114, replyNumber=0, likeNumber=80, createdTime=2021-08-29, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cea920e84114, moduleTitle=J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cea920e84114)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1651986, encodeId=1f0816519866e, content=<a href='/topic/show?id=3a3e1e9504' target=_blank style='color:#2F92EE;'>#ACA#</a>, objectTitle=Acad Pediatr：卡路里、咖啡因与幼儿肥胖症发生之间的关系, objectType=article, longId=215010, objectId=72ea21501027, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=72ea21501027, replyNumber=0, likeNumber=76, createdTime=2022-04-15, rootId=0, userName=lishizhe, userId=843c24278901, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=72ea21501027, moduleTitle=Acad Pediatr：卡路里、咖啡因与幼儿肥胖症发生之间的关系, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=72ea21501027)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

ACA

2020-05-29

lishizhe (审核中...)

前往app查看评论内容

#ACA#

联拓生物完成Mavacamten在中国健康志愿者中的I期药代动力学研究

2023-02-03

lishizhe (审核中...)

前往app查看评论内容

#ACA#

Endocrinol Metab：患者PRKACA L206R突变体产生皮质醇腺瘤的临床和分子特征

2022-04-14

lishizhe (审核中...)

前往app查看评论内容

#ACA#

CACA中国肿瘤整合诊治指南精读巡讲

2022-12-10

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：Ustekinumab治疗儿童斑块型银屑病的真实经验

2022-03-30

lishizhe (审核中...)

前往app查看评论内容

#ACA#

尘螨变应原舌下片ACARIZAX® 豁免中国注册临床试验，2022年将提交上市许可申请

2023-02-07

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol ：组织蛋白酶S抑制剂对中、重度银屑病患者疗效和安全性的研究

2022-09-25

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Orthop Surg：过氧化氢溶液可有效减少术区痤疮杆菌的负担

2022-10-24

lishizhe (审核中...)

前往app查看评论内容

#ACA#

EXPLORER-CN 3期临床试验：Mavacamten治疗有症状的梗阻性肥厚型心肌病在中国完成首例患者给药

2022-11-14

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：古塞奇尤单抗治疗银屑病5年的安全性证据：VOYAGE 1和2研究的汇总数据

2022-05-07

lishizhe (审核中...)

前往app查看评论内容

#ACA#

ACAS应该选择BMT还是CEA/CAS？

2022-01-28

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Dermatol：外用特比萘芬10%溶液（MOB-015）可有效且安全的治疗轻中度手足癣

2021-11-11

lishizhe (审核中...)

前往app查看评论内容

#ACA#

肥厚型心肌病患者新选择！联拓生物合作伙伴百时美施贵宝公司的Camzyos (mavacamten) 获美国FDA批准

2022-06-23

lishizhe (审核中...)

前往app查看评论内容

#ACA#

Clin Cancer Res：派姆单抗联合Acalabrutinib治疗复发/转移性头颈鳞状细胞癌

2022-01-10

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：口服胶质蛋白保护的超氧化物歧化酶是治疗非节段型白癜风的有效补充疗法

2022-08-14

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：局部使用Thiamidol VS. 4%氢醌霜治疗面部黄褐斑的疗效和安全性

2022-09-11

lishizhe (审核中...)

前往app查看评论内容

#ACA#

NEJM： HIF-2α抑制剂Belzutifan有望用于治疗Pacak-Zhuang综合征

2022-10-11

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Eur Acad Dermatol Venereol：对于6月至6岁的严重未受控制的特应性皮炎儿童，单剂量度匹鲁单抗的耐受性良好

2022-03-17

lishizhe (审核中...)

前往app查看评论内容

#ACA#

Proc Natl Acad Sci ：为什么在听到响亮的声音后短暂失去了听力？

2022-05-27

lishizhe (审核中...)

前往app查看评论内容

#ACA#

J Am Acad Child Adolesc Psychiatry：亚临床阶段强迫症CSTC连接性的改变导致成年后强迫症易感性增加

2021-08-29

lishizhe (审核中...)

前往app查看评论内容

#ACA#

Acad Pediatr：卡路里、咖啡因与幼儿肥胖症发生之间的关系

2022-04-15

科室
- - 订阅+
  - 更多科室
工具
服务